Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05563402Not ApplicableCompleted

"Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis"

Role: lead

NCT06615947Not ApplicableCompleted

Conventional Multidisciplinary Gait Rehabilitation VR Robotic Self-balancing Based Gait Rehabilitation

Role: lead

NCT07178834Not ApplicableActive Not Recruiting

Impact of a Tele-rehabilitation Program on People With Multiple Sclerosis

Role: lead

NCT03976128Not ApplicableCompleted

Endurance and Walking Training by Nordic Walking in Multiple Sclerosis

Role: lead

All 4 trials loaded